| 2024/04/17 08:01:57 | |
|---|---|
| Price | |
| 50.02 EUR | |
| Difference | -0.32% (-0.16) |
General attributes
| ISIN | US45337C1027 |
| Symbol | INCY |
| Exchange | Frankfurt |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 11,095 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 50.02 EUR |
| High | 50.02 EUR |
| Low | 50.02 EUR |
| Close (prev. day) | 50.18 EUR |
| VWAP | 51.22 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 2 |
| Last size | 0 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: INCYTE CORP |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/17 08:01:57 | |
|---|---|
| Price | |
| 50.02 EUR | |
| Difference | -0.32% (-0.16) |
General attributes
| ISIN | US45337C1027 |
| Symbol | INCY |
| Exchange | Frankfurt |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 11,095 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 50.02 EUR |
| High | 50.02 EUR |
| Low | 50.02 EUR |
| Close (prev. day) | 50.18 EUR |
| VWAP | 51.22 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 2 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -7.98% | -26.12% | -27.84% |
| Perf (abs.) | -4.34 | -17.68 | -19.30 |
| Beta | 0.47 | 0.42 | 0.51 |
| Volatility | 30.38 | 27.60 | 27.18 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 50.58 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 52.51 EUR (13) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 54.16 EUR (119) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 55.66 EUR (63) |
| YTD High | date | 60.74 EUR (2024/01/05) |
| YTD Low | date | 50.02 EUR (2024/04/17) |
| 52 Weeks High | date | 68.70 EUR (2023/05/02) |
| 52 Weeks Low | date | 47.62 EUR (2023/11/28) |
All listings for INCYTE CORP
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/04/17 | 22:26 | 49.40 EUR | 0.00 | 3 |
| Stuttgart | 2024/04/17 | 18:49 | 49.71 EUR | 0.00 | 6 |
| Nasdaq | 2024/04/17 | 22:00 | 52.72 USD | 134.07 | 24,613 |
| Munich | 2024/04/17 | 08:04 | 50.26 EUR | 0.00 | 2 |
| London Stock Exchange | 2023/02/16 | 18:03 | 79.48 USD | 0.10 | 1 |
| Hanover | 2024/04/17 | 08:00 | 50.02 EUR | 0.00 | 3 |
| Frankfurt | 2024/04/17 | 08:01 | 50.02 EUR | 0.00 | 2 |
| Euronext Milan MTF Trading After Hours | 2024/04/16 | 20:26 | 49.31 EUR | 0.00 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/04/17 | 17:44 | 50.02 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/17 | 19:31 | 50.16 EUR | 0.00 | 7 |
| Berlin | 2024/04/17 | 20:30 | 49.80 EUR | 0.00 | 18 |
Company Logo
Contact Details
| INCYTE CORP. |
| - - |
| 1801 Augustine Cut-Off - 19803 Wilmington |
| Telefon: +1-302-498-6700 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: INCYTE CORP | |
Company Profile
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE. |
Members of Management Board
| Edmund Harrigan | Member of Board of Directors |
| Jacqualyn Fouse | Member of Board of Directors |
| Katherine High | Member of Board of Directors |
| Otis Brawley | Member of Board of Directors |
| Susanne Antonie Schaffert | Member of Board of Directors |
| Jean-Jacques Bienaimé | Member of Board of Directors |
| Julian Baker | Member of Board of Directors |
| Paul Clancy | Member of Board of Directors |
| Hervé Hoppenot | Chairman of Managing Board |
| Barry P. Flannelly | Member of Executive Committee |
| Lothar H. Finke | Member of Executive Committee |
| Steven H. Stein | Member of Executive Committee |
| Christiana Stamoulis | Member of Executive Committee |
| Denise Brashear | Member of Executive Committee |
| Jonathan E. Dickinson | Member of Executive Committee |
| Michael Morrissey | Member of Executive Committee |
| Pablo J. Cagnoni | Member of Executive Committee |
| Paula J. Swain | Member of Executive Committee |
| Sheila A. Denton | Member of Executive Committee |
| Vijay Iyengar | Member of Executive Committee |
| Xiaozhao Wang | Member of Executive Committee |